Zydus Wellness buys UK’s Comfort Click for ₹2,300+ cr: Vitamins, gummies & pet health go global
Opening Hook
While Dalal Street was still digesting Reliance’s green energy musings, Zydus Wellness quietly pulled off a ₹2,300+ crore overseas binge. On 29th August 2025, its UK arm Alidac acquired Comfort Click Limited (CCL), a digital-first vitamins, minerals & supplements (VMS) player with turnover of GBP 134 million (~₹1,430 cr). Why now? Because the global wellness market isn’t waiting—Europe’s VMS industry alone is ~GBP 11 bn, and CCL has clocked a 57% CAGR in five years. India’s sugar-free maker is now selling collagen gummies to kids in London and multivitamins to dogs in Berlin. And yes, this is Zydus’ first-ever foreign buyout—worth chewing over.
At a Glance
Deal size GBP 239 mn – That’s ~₹2,300 cr, not pocket change for stevia sachets.
Comfort Click turnover GBP 134 mn – Grew from GBP 52 mn in FY23; FT called it top-1000 fastest growing.
EBITDA GBP 21 mn – Yes, even gummies sweat margins.
Three brands – WeightWorld (adults), maxmedix (kids), Animigo (pets).
Channel mix – 80%+ via e-commerce/D2C, no kirana store headaches.
Strategic logic – Expands Zydus from Glucon-D to global gummies.
Management’s Key Commentary
Sharvil Patel, Chairman: “The global acquisition marks a step in empowering consumers and shaping future wellness.” → Translation: From sugar-free pills to TikTok gummies, we want it all.
Tarun Arora, CEO: “Aligns with our strategic vision of expanding Zydus’ international footprint.” → Translation: Finally, something more exotic than launching Complan Nutrigro.
On nuclear growth (oops wrong call, here supplements): “CCL is digital-first, consumer-centric and innovation-driven.” → Translation: We just bought the Nykaa of vitamins.
On synergies: “Acquisition expected to be EPS accretive.” → Translation: Relax, analysts—your Excel models won’t faint.
On portfolio: “Adult, paediatric, and pet nutrition categories drive diversification.” → Translation: If kids don’t eat gummies, the family dog surely will.
On vision: “We’re exploring scalable, sustainable models in personalised wellness.” → Translation: Fancy way of saying: more SKUs, more clicks.
Numbers Decoded
Metric
FY23
FY24
FY25 (unaudited)
Analysis
Revenue – The Hero
GBP 52 mn
GBP 85 mn
GBP 134 mn
A CAGR of 57%—Zydus bought a running treadmill.
EBITDA – The Sidekick
—
—
GBP 21 mn
Margins lean but improving—protein bars > Glucon-D sachets.
Turnover CAGR – The Drama Queen
—
—
5 years: 57%
Even crypto bros would envy this chart.
Analyst Questions
Why pay GBP 239 mn? Because VMS is GBP 11 bn in Europe. → Translation: Growth story > sticker shock.
Working capital strain? Comfort Click runs D2C, cash cycles cleaner. → Translation: No kirana wallahs chasing 90-day credit.